
Loading, please wait...

Loading, please wait...

The Food Safety and Standards Authority of India (FSSAI) has significantly intensified its regulatory enforcement against deceptive marketing tactics and misleading food labels across the country. In a decisive regulatory move, the apex food safety authority directed multiple leading consumer brands to immediately eliminate unsubstantiated absolute claims from their packaging and advertising. Consequently, several high-profile food business operators have complied with the statutory directives, removing absolute representations such as "100 per cent" from their commercial inventory. This regulatory intervention marks a crucial milestone in safeguarding public health and ensuring genuine transparency in nutritional declarations.
Food regulators have systematically identified that absolute marketing phrases such as "100 per cent pure" or "100 per cent natural" create an unwarranted perception of flawless quality. Under the statutory framework established by the Food Safety and Standards Act of 2006, commercial declarations must remain completely truthful, verifiable, and unambiguous. However, multiple commercial brands have historically used superlative claims without presenting verifiable analytical evidence to regulatory bodies. Therefore, FSSAI issued formal advisories prohibiting the casual use of absolute percentages on packaged items.
Furthermore, regulatory authorities noted that the phrase "100 per cent" is not legally defined within the Food Safety and Standards (Advertising and Claims) Regulations. Consequently, when manufacturers display such claims on retail packages, consumers frequently assume absolute superiority over standard market alternatives. In addition, these unverified statements unfairly disadvantage compliant competitors who accurately describe their nutritional compositions. Thus, the current regulatory push establishes strict accountability across commercial supply channels.
Following targeted interventions by the food authority, six prominent food business operators have officially executed comprehensive corrective measures. Specifically, Amway India Enterprises Private Limited discontinued the claim "100% Pure Coconut Oil" across its packaged lines and promotional media. Moreover, the enterprise confirmed that older inventories carrying this terminology were systematically recalled from retail distribution networks. Similarly, Emami Limited addressed regulatory notices by removing the "100 per cent" claim previously featured on its Zandu Honey packaging.
Additionally, Apis India implemented comparable rectifications by withdrawing unverified percentage declarations from its honey products. Meanwhile, Bonn Biscuits Private Limited eliminated promotional claims regarding its cumin-flavored biscuits from digital portals. Crucially, the crackdown extended beyond adult retail foods into sensitive categories. For instance, Juza Foods in Kerala withdrew misleading absolute claims from several infant food products. Similarly, Masterchow Foods removed ambiguous declarations from its noodle offerings, demonstrating comprehensive industry compliance across diverse sectors.
Deceptive food claims represent significant public health concerns, particularly for vulnerable populations managing metabolic disorders. When consumers encounter absolute claims, they often develop a false sense of health security regarding processed commodities. For example, marketing high-sugar items or processed snacks with healthy descriptors can misguide diabetic patients into higher caloric consumption. Consequently, patients may inadvertently compromise their glycaemic control, lipid balance, and overall cardiovascular health.
Furthermore, deceptive claims in pediatric nutrition present serious long-term developmental risks. When commercial baby food brands advertise absolute purity, parents might assume the product is inherently superior to wholesome homemade alternatives. However, many processed weaning formulations continue to harbor significant sodium, preservatives, or hidden sugars. Therefore, physicians and dietitians emphasize that transparent ingredient lists are indispensable for proper pediatric growth. By curbing misleading promotional terminology, regulatory bodies empower consumers to make clinically sound dietary selections.
The Food Safety and Standards (Advertising and Claims) Regulations of 2018 provide the legal backbone for truth in commercial food advertising. Sub-regulation 4(1) explicitly mandates that every commercial declaration must be clear, scientifically robust, and readily comprehensible to everyday shoppers. Moreover, Sub-regulation 10(7) firmly prohibits any promotional campaign that undermines competitors or artificially distorts fair consumer judgment. Therefore, businesses must maintain empirical scientific substantiation before printing nutritional statements on retail packaging.
In recent months, regulatory scrutiny has widened beyond packaged groceries to include carbonated beverages, energy drinks, and alcoholic products. For instance, authorities recently issued corrective notices to prominent conglomerates like Dabur India and Ferns N Petals regarding product classification anomalies. When food items masquerade as proprietary Ayurvedic medicines or conceal synthetic vegetable fats, regulatory authorities intervene aggressively. Consequently, food safety officers across states are executing routine retail audits to guarantee complete conformity with national food safety codes.
Medical practitioners, clinical nutritionists, and general physicians serve as the primary line of defense against deceptive food marketing. During routine clinical consultations, healthcare professionals must educate patients on how to scrutinize nutritional panels rather than relying on promotional front-of-pack graphics. Specifically, clinicians should instruct individuals to inspect total caloric density, added sucrose levels, sodium amounts, and saturated fatty acid concentrations. This proactive guidance directly helps mitigate chronic lifestyle disorders, including obesity, hypertension, and non-alcoholic fatty liver disease.
Additionally, doctors should encourage families to prioritize minimally processed, locally sourced whole foods over packaged commercial alternatives. When advising parents regarding infant nutrition, clinicians should reinforce the unparalleled physiological benefits of exclusive breastfeeding and balanced complementary feeding. Furthermore, healthcare professionals can report suspicious health claims or blatantly deceptive labels to relevant statutory watchdogs. Through active clinical vigilance and patient advocacy, the medical community significantly strengthens national public health initiatives.
Q1: Why did FSSAI prohibit the use of 100 percent claims on packaged food items?
The regulator prohibited these claims because the term "100 per cent" lacks a statutory definition under national food laws. Absolute assertions often deceive consumers into assuming unmatched purity or superiority. Consequently, manufacturers used these vague phrases without providing validated scientific substantiation. The ban ensures truthful marketing, promotes fair market competition, and protects consumer welfare across all commercial product categories.
Q2: How do misleading food labels directly impact patient health and chronic disease management?
Deceptive labels can lead individuals with chronic metabolic conditions, such as diabetes or hypertension, to miscalculate their actual nutritional intake. When processed products falsely project absolute healthfulness, consumers may consume excessive hidden sugars, sodium, or unhealthy fats. Consequently, this unmonitored dietary intake impairs therapeutic control, aggravates metabolic dysregulation, and increases long-term risks of cardiovascular and renal complications.
Q3: What specific label information should consumers check instead of relying on front-of-pack marketing claims?
Consumers and patients should carefully examine the mandatory back-of-pack nutritional facts panel and the comprehensive ingredient declaration. Specifically, they should inspect the exact serving size, total carbohydrates, added sugars, saturated fats, trans fats, and sodium levels. Checking for certified quality logos, such as the Jaivik Bharat mark for genuine organic goods, provides reliable verification rather than superficial marketing slogans.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Following strict regulatory enforcement by the Food Safety and Standards Authority of India, prominent consumer brands have withdrawn misleading 100 percent claims from product packaging and advertisements. This initiative aims to protect consumer welfare and eliminate deceptive commercial marketing.
2 months ago

Central chronotropic incompetence is an underrecognized sequela of rhombencephalitis causing exertional dyspnea despite normal resting cardiac function. Cardiopulmonary exercise testing unmasks this heart-brain uncoupling, guiding rate-responsive pacing and targeted rehabilitation.
Today

A landmark study reveals that lipid-rich malignant ascites alters the T-cell metabolic transcriptome, causing cholesterol efflux and impaired fatty acid oxidation. This suppresses TCR signalling and blocks BiTE immunotherapy, while lipid depletion restores antitumour cytotoxicity in ovarian cancer.
Today

A registry study of 4,989 patients evaluates transvenous lead extraction for right-sided cardiac devices. Despite longer dwell times and older leads, right-sided extractions achieve high procedural success and comparable safety to left-sided approaches.
Today

Recent crash analyses demonstrate significant variations in traffic injury severity across vehicle seating positions. Electric vehicle passengers face disproportionately higher trauma risks than drivers, particularly during airbag deployments, demanding adapted emergency assessment and clinical vigilance.
Today

Understand the causal role of Lipoprotein(a) in cardiovascular disease, why international guidelines recommend once-in-a-lifetime molar testing, and the clinical implications of recent phase 3 RNA outcome trials.
Today